Longitudinal study of the effects of bacteremia and sepsis on 5-year risk of cardiovascular events

Clinical Infectious Diseases

Volumn 63, Issue 4, 2016, Pages 495-500

  Jafarzadeh, S Reza ^a   Thomas, Benjamin S ^a,b   Warren, David K ^a   Gill, Jeff ^a,c   Fraser, Victoria J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c Division of Biostatistics   (United States)

Author keywords

Bloodstream infection; Causal inference; Inverse probability weighting; Marginal structural model; Time varying confounding

Indexed keywords

ADULT; ARTICLE; BACILLUS INFECTION; BACTEREMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CORYNEBACTERIUM INFECTION; FEMALE; HEART INFARCTION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROCOCCUS INFECTION; MIDDLE AGED; MISSOURI; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM INFECTION; SEPTIC SHOCK; STAPHYLOCOCCUS INFECTION; TERTIARY CARE CENTER; TRANSIENT ISCHEMIC ATTACK; UNIVERSITY HOSPITAL; COMPLICATION; RISK; SEPSIS; STATISTICAL MODEL;

BACTEREMIA; FEMALE; HOSPITALIZATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MISSOURI; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; RISK; SEPSIS; SHOCK, SEPTIC; STROKE;

EID: 84982085571     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw320     Document Type: Article

References (39)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014; 129:e28-292
2. Grundy SM, Balady GJ, Criqui MH, et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 1998; 97:1876-87
3. Roivainen M, Viik-Kajander M, Palosuo T, et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 2000; 101:252-7
4. Smieja M, Gnarpe J, Lonn E, et al. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2003; 107:251-7
5. Paganini-Hill A, Lozano E, Fischberg G, et al. Infection and risk of ischemic stroke: differences among stroke subtypes. Stroke J Cereb Circ 2003; 34:452-7
6. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351:2611-8
7. Corrales-Medina VF, Fatemi O, Serpa J, et al. The association between Staphylococcus aureus bacteremia and acute myocardial infarction. Scand J Infect Dis 2009; 41:511-4
8. Corrales-Medina VF, Serpa J, Rueda AM, et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore) 2009; 88:154-9
9. Elkind MSV, Carty CL, O'Meara ES, et al. Hospitalization for infection and risk of acute ischemic stroke: the Cardiovascular Health Study. Stroke J Cereb Circ 2011; 42:1851-6
10. Walkey AJ,Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA 2011; 306:2248-54
11. Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 2012; 125:773-81
12. Dalager-Pedersen M, Søgaard M, Schønheyder HC, Nielsen H, Thomsen RW. Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study. Circulation 2014; 129:1387-96
13. Donzé JD, Ridker PM, Finlayson SRG, Bates DW. Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study. BMJ 2014; 349:g5334
14. Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA 2015; 313:264-74
15. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010; 10:83-92
16. Fugate JE, Lyons JL, Thakur KT, Smith BR, Hedley-Whyte ET, Mateen FJ. Infectious causes of stroke. Lancet Infect Dis 2014; 14:869-80
17. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133:144-53
18. Elixhauser A, Friedman B, Stranges E. Septicemia in U.S. hospitals, 2009: statistical brief no.122. In: Healthcare Cost and Utilization Project (HCUP) statistical briefs. Rockville, MD: Agency for Health Care Policy and Research, 2011. Available at: http://www.ncbi.nlm.nih.gov/books/NBK65391/. Accessed 27 March 2014
19. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998; 36:8-27
20. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43:1130-9
21. Edwards JR, Pollock DA, Kupronis BA, et al. Making use of electronic data: the National Healthcare Safety Network eSurveillance Initiative. Am J Infect Control 2008; 36:S21-6
22. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-55
23. Kaukonen K-M, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 2015; 372:1629-38
24. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11:550-60
25. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol 2008; 168:656-64
26. Daniel RM, Cousens SN, De Stavola BL, Kenward MG, Sterne JAC. Methods for dealing with time-dependent confounding. Stat Med 2013; 32:1584-618
27. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology 1999; 10:37-48
28. Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res 2013; 22:278-95
29. D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med 1990; 9:1501-15
30. Abbott RD. Logistic regression in survival analysis. Am J Epidemiol 1985; 121:465-71
31. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11:561-70
32. van derWalWM, Geskus RB. ipw: an R package for inverse probability weighting. J Stat Softw 2011; 43:1-23
33. Grau AJ, Urbanek C, Palm F. Common infections and the risk of stroke. Nat Rev Neurol 2010; 6:681-94
34. Jafarzadeh SR, Thomas BS, Marschall J, Fraser VJ, Gill J,Warren DK. Quantifying the improvement in sepsis diagnosis, documentation, and coding: the marginal causal effect of year of hospitalization on sepsis diagnosis. Ann Epidemiol 2016; 26:66-70
35. Thomas BS, Jafarzadeh SR, Warren DK, McCormick S, Fraser VJ, Marschall J. Temporal trends in the systemic inflammatory response syndrome, sepsis, and medical coding of sepsis. BMC Anesthesiol 2015; 15:169
36. Lange T, Vansteelandt S, Bekaert M. A simple unified approach for estimating natural direct and indirect effects. Am J Epidemiol 2012; 176:190-5
37. Vanderweele TJ, Vansteelandt S, Robins JM. Marginal structural models for sufficient cause interactions. Am J Epidemiol 2010; 171:506-14
38. VanderWeele TJ, Tchetgen Tchetgen EJ. Attributing effects to interactions. Epidemiology 2014; 25:711-22
39. Funk MJ, Westreich D, Wiesen C, Stürmer T, Brookhart MA, Davidian M. Doubly robust estimation of causal effects. Am J Epidemiol 2011; 173:761-7